The aforementioned molecules can upregulate p53 acetylation or induce pro-apoptotic, SIRT1-epigenetically silenced gene expression to suppress BC cell growth and trigger p53-dependent apoptosis (Peck et al., 2010). This evidence concerns the gene TP53 and breast cancer.